Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date The exogenously driven disruption of Bioprocessing Christos Varsakelis, at The Janssen Pharmaceutical Companies of J&J and Pranjul Mishra, at Yokogawa Insilico Biotechnology Industry 4.0 comes with an impressive collection of assets and capabilities. However, although the degree of applicability in Bioprocessing is high, t... September 15, 2022 2:00pm Data as an asset – what does this mean to you? Christos Varsakelis, at The Janssen Pharmaceutical Companies of Johnson & Johnson Social media frequently depict data as the new oil. Whilst Industry 4.0 is data centric, in the sense that it promotes a data driven “piloting of the ... 3 months ago | 78 mins Holistic Approach to the Industry 4.0... Christos Varsakelis, at The Janssen Pharmaceutical Companies of J&J and Shilpa Nargund, Director at Insilico Biotechnology Full Title: Holistic Approach to the Industry 4.0 Investment Breaking Down the Fences Between R&D & Manufacturing Bioprocessing 4.0 is a novel termin... 4 months ago | 87 mins Janssen's Real Time release: Using MSPC to enhance batch release. Sarah Nielsen, at Janssen and Herman He, at Thermo Fisher Scientific The Janssen real time release strategy will be presented. Multivariate statistical process modeling is used as a way to guide batch release (either vi... 10 months ago | 80 mins Janssen CM-strategy: A Story of Multiple Platforms From R&D to Commercial Presented by Jeroen Geens, Engineering Technical Director at Janssen Research & Development After initial CM projects and successes for specific compounds in its commercial portfolio, Janssen defined in 2015 a vision to make continuous manufa... 2 years ago | 103 mins Strategies to Overcome Low Endotoxin Recovery Using the Conventional LAL Assay Ruth Daniels, Senior Scientist, Microbiology Expert, Janssen and Kevin Williams Microbiological Test Development, bioMérieux Presented by Dr. Ruth Daniels, Senior Scientist - Microbiology Expert at Janssen This webinar presentation will discuss: • Endotoxin hold time studi... 2 years ago | 68 mins Quality-By-Design in Spray Drying Processes - Transfer Lab to Production Sune Klint Andersen, Janssen Pharmaceutica & João Vicente Senior Scientist - Particle Engineering Team Leader at Hovione Spray drying is a continuous and scalable manufacturing process commonly used in the pharmaceutical industry. Due to its scalable and continuous natur... 3 years ago | 77 mins From Early Stage to Late Stage Development: How to Characterize a Perfusion-base Perrine Rouel, Janssen Pharmaceutical Companies of Johnson & Johnson and Tom Jeffery, Sartorius Stedim Biotech Full Title: From Early Stage to Late Stage Development: How to Characterize a Perfusion-based Vaccine Production Process Using QbD? The biopharmaceut... 3 years ago | 58 mins New Drying Processes for Biopharmaceuticals Sune Klint Andersenand Principal Scientist at Janssen Pharmaceutical and Lars Markwort, co-founder and CEO of Bioinicia SL Presented by Sune Klint Andersen, Principal Scientist at Janssen Pharmaceutical Companies of Johnson & Johnson Sune Klint Andersen is Principal Scien... 2 years ago | 91 mins The Journey Of Implementing Advanced Process Control In the Pharmaceutical... Olav Lyngberg, Sr Scientific Fellow at Janssen Pharma and Mark Demesmaeker Head of Data Analytics at Sartorius Stedim Biotech Full Title: The Journey Of Implementing Advanced Process Control In the Pharmaceutical Industry Presented by Olav Lyngberg, PhD, Sr. Scientific Fellow... 2 years ago | 77 mins